JAVMA news
Warning added to euthanasia products
The FDA's Center for Veterinary Medicine is adding an environmental warning to labels of pentobarbital-containing euthanasia
JAVMA news
All hydrocodone products now schedule II drugs
The Drug Enforcement Administration has scheduled all hydrocodone-containing products as schedule II drugs
JAVMA news
FDA advises stricter oversight for hydrocodone products
The Food and Drug Administration believes stricter oversight is necessary for hydrocodone combination products to curb abuse
policy
Sale of human-label drug products to veterinarians
Because there are a limited number of drugs labeled for use in animals, veterinarians need to have access to human-labeled prescription drugs to…
blog
Farm bill delivers victory for veterinary medicine
The nation’s new farm bill creates critical programs to improve animal health and enhance the nation’s ability to prevent and respond to animal…
JAVMA news
Seresto collars come under greater scrutiny
Recent adverse event reports from pet owners related to a popular brand of flea and tick collars have gained national attention. The manufacturer has…
JAVMA news
More opioids available to veterinarians during ongoing shortage
The Food and Drug Administration announced Dec. 13 that the agency has worked with Pfizer Inc. to help alleviate a shortage of certain injectable…
JAVMA news
A closer look at veterinary homeopathy
Homeopathy is, depending on whom you ask, a gentler and more natural alternative to traditional medicine or an unproven and useless modality, at best.
JAVMA news
The slow rise of generic animal drugs
In human medicine, generic drugs accounted for 88 percent of prescriptions dispensed in the United States as of 2014.
JAVMA news
People ingesting veterinary-use ivermectin in attempts to prevent, cure COVID-19
Health authorities are again warning people not to consume veterinary-use ivermectin products as poison control centers receive a surge in calls about…
JAVMA news
DEA provides update on opioid shortage
The Drug Enforcement Administration released a statement April 10 on the ongoing opioid shortages affecting both human and veterinary medicine.
JAVMA news
FDA amends rules on adverse drug experience records
Posted on April 15, 2002 The Food and Drug Administration Center for Veterinary Medicine is amending the requirements for records, reports of…
JAVMA news
Concentration labeling changed for epinephrine, two other medications
Three human-use pharmaceuticals used in veterinary medicine will be sold with labels containing revised descriptions of drug concentrations.
JAVMA news
1975 - 1985
Production of JAVMA moved in April 1975 to the AVMA’s first owned headquarters, newly constructed in Schaumburg, Illinois, and dedicated that October.
JAVMA news
AVMA presents Excellence Awards for 2019
During AVMA Convention 2019 this August in Washington, D.C., a number of individuals received AVMA Excellence Awards for contributions in areas such…
policy
Funding of the New Animal Drug Application (NADA) and Abbreviated New Animal Drug Application (ANADA) approval process
To help ensure adequate availability of veterinary drugs, the AVMA supports increased funding of the FDA Center for Veterinary Medicine for the NADA…
JAVMA news
FDA’s Dunham delves into drug issues
Dr. Bernadette Dunham, director of the Food and Drug Administration’s Center for Veterinary Medicine, recently fielded questions about drug issues and…
Over-the-counter antimicrobials changing to prescription-only
The FDA has outlined its process for changing certain medically important antimicrobial drugs from over-the-counter (OTC) to prescription (Rx). Rx…
JAVMA news
Senate passes World Veterinary Year resolution
The Senate passed a resolution Sept. 23 marking the upcoming 250th anniversary of veterinary medicine by proclaiming 2011 as World Veterinary Year.
JAVMA news
The hype and hope of veterinary cannabis
A range of issues were covered at the first AVMA Cannabis Symposium, from regulatory and toxicological concerns to the drug’s potential as a…
policy
Veterinary compounding
Compounding is the customized manipulation of a drug by a veterinarian, or by a pharmacist upon the prescription of a veterinarian, to meet the needs…
AVMA news
More options expected for treating rare conditions in dogs and cats
The Food and Drug Administration’s Center for Veterinary Medicine announced plans to increase the maximum numbers of dogs and cats that can be…
policy
Adverse event reporting
The AVMA encourages veterinarians to report adverse events, and encourages continued development and strengthening of adverse event reporting systems.
JAVMA news
FDA describes legal limits of drug compounding
Agency says few uses allowed for raw active ingredients
JAVMA news
Cannabis research for veterinary patients advancing, cautiously
More than half the country has legalized marijuana use in one form or another.